Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Venture Capital
Founders Alex Kolicich Drew Oetting Jake Medwell Joe Lonsdale Kimmy Scotti


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 367
Average round size
The average size of a deal this fund participated in
Portfolio companies 235
Rounds per year 45.88
Lead investments 30
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 15
Key employees 13
Stages of investment

Areas of investment

  • Software
  • Health Care
  • SaaS
  • Biotechnology
  • Information Technology

8VC appeared to be the VC, which was created in 2015. The company was established in North America in United States. The main department of described VC is located in the San Francisco.

This organization was formed by Alex Kolicich, Drew Oetting, Jake Medwell, Kimmy Scotti. We also calculated 9 valuable employees in our database.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the 8VC, startups are often financed by Y Combinator, Thrive Capital, Sway Ventures. The meaningful sponsors for the fund in investment in the same round are SV Angel, Lightspeed Venture Partners, Great Oaks Venture Capital. In the next rounds fund is usually obtained by Founders Fund, Menlo Ventures, Emergence.

This 8VC works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. The higher amount of exits for fund were in 2019. The fund is constantly included in 25-48 deals per year. The average startup value when the investment from 8VC is 500 millions - 1 billion dollars.

The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Oscar Health Insurance Co., Flexport, Guardant Health We can highlight the next thriving fund investment areas, such as Biotechnology, SaaS. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of 8VC:
Typical Co-investors
8VC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after 8VC:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oula Health

Health Care
Personal Health
$19M12 Jan 2023 New York, New York, United States

Mantra Bio

Life Science
$9M04 Jan 2023 San Francisco, California, United States

Second Front Systems

Information Services
Information Technology
National Security
$32M07 Dec 2022 Arlington, Virginia, United States

Telegraph System

Machine Learning
$10M06 Dec 2022 Chicago, Illinois, United States


Brand Marketing
Digital Marketing
Loyalty Programs
$3M09 Nov 2022 New York, New York, United States

Cambium Biomaterials

Renewable Energy
01 Nov 2022 Berkeley, California, United States


Health Care
Information Services
Information Technology
$3M25 Oct 2022 -

Wispr AI

Artificial Intelligence
Consumer Electronics
$10M24 Oct 2022 San Francisco, California, United States

SURGE Therapeutics

$26M17 Oct 2022 Cambridge, Massachusetts, United States
Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes

– Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, announced that it has raised $61 million to fuel the continued development of its platform to design and develop new therapeutics mined from microbial genomes.
Nextech Invest led the financing, with participation from new investors SoftBank Vision Fund 2* and Casdin Capital, as well as existing investors The Column Group, 8VC, and Two Sigma Ventures.
– Hexagon’s interdisciplinary platform combines technological advances and proprietary insights across machine learning, genomics, synthetic biology and automation to systematically discover new chemical compounds linked to known protein targets.
– Hexagon has built a database of microbial genomes that is more than twice the size of all public databases and is adding thousands of additional genomes per month.

Flywheel Raises $22M in Series C Funding

– Flywheel announces a $22m Series C funding round.
– The round was led by 8VC and includes iSelect, Argonautic Ventures, Beringea, Novartis, HPE Pathfinder, Spike Ventures, Key Investments, Seraph, Great North Labs and others.
– Flywheel’s cloud-based data management platform enables researchers to accelerate discovery through streamlined data curation and management, automated pipelines for machine learning and analysis, and tools to ensure secure collaboration.
– With Flywheel’s platform in place, researchers across academic, clinical and life sciences organizations can transform productivity and accelerate innovation in imaging research, multicenter studies, AI development and clinical trials.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent 8VC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: